These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19816024)

  • 1. Total blood volume is maintained in nonhydropic fetuses with severe hemolytic anemia.
    Pasman SA; van den Brink CP; Kamping MA; Adama van Scheltema PN; Oepkes D; Vandenbussche FP
    Fetal Diagn Ther; 2009; 26(1):10-5. PubMed ID: 19816024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal platelet counts correlate with the severity of the anemia in red-cell alloimmunization.
    Saade GR; Moise KJ; Copel JA; Belfort MA; Carpenter RJ
    Obstet Gynecol; 1993 Dec; 82(6):987-91. PubMed ID: 8233277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrops in fetal sheep from rapid induction of anemia.
    Blair DK; Vander Straten MC; Gest AL
    Pediatr Res; 1994 May; 35(5):560-4. PubMed ID: 8065838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin in human fetuses with immune hemolytic anemia and hydrops fetalis.
    Moya FR; Grannum PA; Widness JA; Clemons GK; Copel JA; Hobbins JC
    Obstet Gynecol; 1993 Sep; 82(3):353-8. PubMed ID: 8355933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
    de Haan TR; van den Akker ES; Porcelijn L; Oepkes D; Kroes AC; Walther FJ
    BJOG; 2008 Jan; 115(1):76-81. PubMed ID: 18053103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluid shift from intravascular compartment during fetal red blood cell transfusion.
    Kamping MA; Pasman SA; Bil-van den Brink CP; Oepkes D; Adama van Scheltema PN; Vandenbussche FP
    Ultrasound Obstet Gynecol; 2013 May; 41(5):550-5. PubMed ID: 23124821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoalbuminemia: a cause of fetal hydrops?
    Pasman SA; Meerman RH; Vandenbussche FP; Oepkes D
    Am J Obstet Gynecol; 2006 Apr; 194(4):972-5. PubMed ID: 16580285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of serial intravascular transfusions in ascitic/hydropic RhD-alloimmunized fetuses.
    Craparo FJ; Bonati F; Gementi P; Nicolini U
    Ultrasound Obstet Gynecol; 2005 Feb; 25(2):144-8. PubMed ID: 15660441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization.
    Lobato G; Soncini CS
    Fetal Diagn Ther; 2008; 24(4):349-52. PubMed ID: 18849608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone concentration in normal, growth-retarded, anemic, and hydropic fetuses.
    Ville Y; Proudler A; Kuhn P; Nicolaides KH
    Obstet Gynecol; 1994 Oct; 84(4):511-4. PubMed ID: 8090385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection.
    Nagel HT; de Haan TR; Vandenbussche FP; Oepkes D; Walther FJ
    Obstet Gynecol; 2007 Jan; 109(1):42-7. PubMed ID: 17197586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine management of fetal parvovirus B19 infection.
    Schild RL; Bald R; Plath H; Eis-Hübinger AM; Enders G; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Mar; 13(3):161-6. PubMed ID: 10204205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal transfusion for red blood cell alloimmunization in pregnancy.
    Schumacher B; Moise KJ
    Obstet Gynecol; 1996 Jul; 88(1):137-50. PubMed ID: 8684747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.
    Fesslova V; Vignati G; Brucato A; De Sanctis M; Butera G; Pisoni MP; Chiappa E; Acaia B; Meroni PL
    Cardiol Young; 2009 Jun; 19(3):282-90. PubMed ID: 19383179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
    Scheier M; Hernandez-Andrade E; Fonseca EB; Nicolaides KH
    Am J Obstet Gynecol; 2006 Dec; 195(6):1550-6. PubMed ID: 16796991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fetal hydrops on the rate of fall of hemoglobin after fetal intravascular transfusion for red cell alloimmunization.
    Abdel-Fattah SA; Carroll SG; Kyle PM; Soothill PW
    Fetal Diagn Ther; 2000; 15(5):262-6. PubMed ID: 10971078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivated fetal haemoglobin as a marker for red cell age in the human fetus reflecting stimulated or impaired red blood cell production.
    Huisman M; Egberts J; van Loon J
    Prenat Diagn; 2001 Jul; 21(7):523-8. PubMed ID: 11494284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.